Navigation Links
Volcano Reports 14 Percent Increase in Fourth Quarter Revenues; Medical Segment Revenues Grow 20 Percent
Date:2/22/2012

SAN DIEGO, Feb. 22, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today said revenues in the fourth quarter of 2011 increased 14 percent versus the fourth quarter of 2010.

For the quarter ended December 31, 2011, Volcano reported revenues of $92.7 million versus revenues of $81.2 million in the fourth quarter a year ago. Year-over-year medical segment revenues increased 20 percent in the fourth quarter of 2011. Industrial segment revenues in the fourth quarter declined 70 percent versus a year ago, due to reduced spending in the telecommunications sector.

The company reported net income on a GAAP basis of $29.4 million, or $0.54 per diluted share, in the fourth quarter of 2011, versus a net loss of $1.7 million, or $0.03 per share, in the fourth quarter of 2010. The results for the fourth quarter of 2011 include a benefit of $22.0 million, or $0.40 per diluted share, related to the release of a portion of the company's deferred tax valuation allowance.

For the full year 2011, Volcano reported revenues of $343.5 million, an increase of 17 percent over revenues of $294.1 million in 2010. Medical segment revenues increased 23 percent and industrial segment revenues decreased 52 percent year-over-year.

The company reported GAAP net income of $38.1 million, or $0.70 per diluted share, in 2011. This compares with GAAP net income of $5.2 million, or $0.10 per diluted share, in 2010. The results for the full year 2011 include the benefit of $22.0 million, or $0.40 per diluted share, related to the release of a portion of the company's deferred tax valuation allowance.

"During the quarter, we continued to advance our mission of being the leading precision guided therapy company by gain
'/>"/>

SOURCE Volcano Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
2. Volcano Corporation Announces Preliminary Fourth Quarter 2011 Revenues
3. Volcano Corporation Presentation at J.P. Morgan Conference to be Webcast
4. Upgraded ACCF/ AHA/ SCAI Guidelines Reinforce Benefits of Volcanos Precision Guided Therapy Technologies
5. Volcano Corporation Announces Upcoming Presentation of Late-Breaking Clinical Trial Results and FFR Product Launch at TCT 2011
6. Volcano Reports 18 Percent Increase in Total Third Quarter Revenues
7. Volcano Corporation Appoints Leslie V. Norwalk and Dr. Eric J. Topol to Board of Directors
8. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
9. Volcano Corporation Announces Presentations at Upcoming Investor Conferences
10. Volcano Reports 22 Percent Increase in Second Quarter Medical Segment Revenues and Earnings per share of $0.09
11. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)...  Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... chronic pain, today announced the appointment of several ... panel of experts will provide support for planning ... the company pipeline of novel investigational therapies to ... range of areas including opioid receptors, addiction, psychiatry, ...
(Date:3/5/2015)... -- LUNGevity Foundation, the nation,s leading lung cancer ... approval of Bristol Myers Squibb,s new immunotherapy drug ... another critical new treatment option to fight lung ... own immune system to fight cancerous cells. Importantly, ... with squamous cell lung cancer, a population for ...
(Date:3/5/2015)... , Mar. 05, 2015 Research and Markets ... the "Japan Pharma Outlook 2015: Year to Watch ... Initiatives" report to their offering. ... from April -2014 (Annexure 1) is a ... - whether generic or innovator. The most of the ...
Breaking Medicine Technology:Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3
... , MISSISSAUGA, Ontario , June 18 CardioGenics ... Care™ Point-Of-Care (POC) analyzer and products for the immunoassay segment of ... at http://www.cardiogenics.com/ataglance/ataglance.pdf , ... The 2-page profile was prepared by Redington, Inc., ...
... June 18 Watson Pharmaceuticals, Inc. (NYSE: ... that Watson management will provide an overview and update of ... Conference on Wednesday, June 23, 2010 at ... Boston . The presentation will be webcast live and can ...
Cached Medicine Technology:New Corporate Profile Posted On CardioGenics' Website 2Watson to Present at the Wells Fargo Securities 2010 Healthcare Conference 2
(Date:3/6/2015)... 06, 2015 As the Mayo Clinic's ... discussed, Ford & Associates Nationwide Legal Services, A.P.C., comments ... filed lawsuit: Verduzco v. Daiichi Sankyo, Inc., Case No. ... , “In light of a recently filed lawsuit, ... to evaluate and explore the Mayo Clinic's Benicar case ...
(Date:3/5/2015)... From Oct. 5-10, Mumbai, India will serve as ... These dates include the following activities:, ... October 6: Conference Day 1, ending with a Fashion ... 2, ending with Local Entertainment and Dinner , ... Materials Meetings , October 9-10: Textiles in India ...
(Date:3/5/2015)... The global digital PCR (dPCR) and qPCR market is ... from 2014 to 2019. , The global digital PCR (dPCR) and ... from 2014 to 2019. Although the mature markets such as the ... PCR (dPCR) and qPCR market the Asia-Pacific region is expected to ... The growth of the digital PCR (dPCR) and qPCR market is ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 This ... formaldehyde in low-cost laminate flooring products, initiating ... manufacturer of eco-friendly building materials made primarily from ... by testing all their flooring products for volatile ... laboratory Benchmark International (BMH). Results from ...
(Date:3/5/2015)... March 05, 2015 AxoGen, Inc. ... on the peripheral nerve repair market, reported record revenue ... 31, 2014 compared to $2.98 million in the year-ago ... growth strategies. , “Our strong fourth quarter revenue ... nerve repair products which is driving increased surgeon adoption ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4Health News:Textile Exchange Announces the 2015 Textile Sustainability Conference Dates 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:With Homeowners Concerned About Formaldehyde, Cali Bamboo Puts Safety Above Bottom Line 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4
... , HOFFMAN ESTATES, Ill., July 16 ... America,s top medical institutions in the annual America,s Best Hospitals list published ... magazine. St. Alexius Medical Center was ranked among the top 50 hospitals ... , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090716/CG47487 ) ...
... NATICK, Mass., July 16 Boston Scientific Corporation (NYSE: ... from the U.S. Food and Drug Administration (FDA) to market ... drug-eluting stent (DES) designed for long lesions. At 38 ... option that can potentially reduce the number of stents used ...
... , PEKIN, Ill., July 16 ... of prescription foot and ankle orthoses and accompanying high technology ... award, which is given annually by the national Department of ... employment opportunities and support to veterans. , ...
... WALTHAM, Mass., July 16 According to Millennium ... intelligence, the fat reduction device market will experience the highest ... MRG,s European Markets for Body Contouring Devices 2009 ... fueled by physician adoption of newer modalities like transdermal ultrasound ...
... , , FRANKLIN, Mass., ... a company focused on innovative cardiac and vascular medical device-based ... Cardiac Angiography in Renally Impaired Patients (CARE) Study determined that ... from pulmonary edema to death, and that patients with CIN ...
... , , , BEIJING, July ... access to fast and efficient radiotherapy treatments with the introduction of ... ) at the Beijing Cancer Hospital. BCH is the first ... more advanced care to a greater number of patients. , ...
Cached Medicine News:Health News:St. Alexius Medical Center Named to America's Best Hospitals Rankings 2Health News:FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent 2Health News:FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent 3Health News:FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent 4Health News:PAL Health Technologies Wins State-Level Prestigious 'Employer of the Year' Award 2Health News:Fat Reduction Market in Europe to Soar Despite Economic Downturn 2Health News:PLC Medical Systems Announces Publication of Care Study Update 2Health News:PLC Medical Systems Announces Publication of Care Study Update 3Health News:Beijing Cancer Hospital Becomes First Hospital in Mainland China to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments 2Health News:Beijing Cancer Hospital Becomes First Hospital in Mainland China to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments 3
... are designed exclusively for video endoscopy and ... Olympus endoscopy systems. When used in conjunction ... provides sharp, high-resolution images with excellent color ... - and details - necessary for accurate ...
... The Sony LMD-151MD LCD monitors are ... years of experience in video technology with ... The monitors comply with key safety requirements ... surgery, patient monitoring, radiology and more. Slim ...
Resorbable fixation system 1.5/2.0....
... intended for visualization of the anatomic structures ... in the brain, evaluation of the brain ... the Sonomed-315 offers quick and reliable detection ... identify the anatomic structures of the brain. ...
Medicine Products: